Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Chicago
- Study ID
- NCT07405424
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- SCORE Intervention — BEHAVIORALParticipants assigned to this arm will receive regularly scheduled visits from the study spiritual care team during their hospital admission (four times within 14 days).
Study Details
This study is being done to determine if it is possible to incorporate spiritual care sessions as part of the care plan for patients hospitalized for leukemia treatment. In this study, participants will be randomly assigned to either no intervention (standard, real world inpatient spiritual care) or to receive study-specific guided spiritual sessions.
Key Dates
- Start date
- Jun 20, 2026
- Status verified
- Feb 2026
- Primary completion
- Jun 16, 2028
- Completion
- Jun 16, 2028
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Spiritual Intervention ArmParticipants receive a study specific spiritual care intervention.
- No Intervention: No Intervention Arm
Primary Outcome Measure
Is it feasible to enroll patients to a spiritual intervention study? [ Time Frame: End of study (approximately 2 years) ]
Central Contacts
- Clinical Trials Intake1-855-702-8222
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UChicago Medicine Comprehensive Cancer Center | Chicago | Illinois | 60637 | Wendy Stock (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chicago, IL
By condition
By specialty
By research site
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and CareRecruiting · University of Miami · Miami, Florida
- Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaPHASE1 · Recruiting · Kura Oncology, Inc. · Gilbert, Arizona